发明名称 Engineering and optimization of improved systems, methods and enzyme compositions for sequence manipulation
摘要 The invention provides for engineering and optimization of systems, methods, and compositions for manipulation of sequences and/or activities of target sequences. Provided are compositions and methods related to components of a CRISPR complex particularly comprising a Cas ortholog enzyme.
申请公布号 US8865406(B2) 申请公布日期 2014.10.21
申请号 US201414222930 申请日期 2014.03.24
申请人 The Broad Institute Inc.;Massachusetts Institute of Technology 发明人 Zhang Feng;Ran Fei
分类号 C12Q1/68;C12N15/85;C12N9/14;C12N9/22;C12N9/52;C12N15/00;C07H21/02;C07H21/04;A61K38/43;A61K38/46;A61K38/47 主分类号 C12Q1/68
代理机构 Vedder Price P.C. 代理人 Vedder Price P.C. ;Kowalski Thomas J.;Lu Deborah L.
主权项 1. A method of altering expression of at least one gene product comprising introducing into a eukaryotic cell containing and expressing a DNA molecule having a target sequence and encoding the gene product an engineered, non-naturally occurring Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-CRISPR associated (Cas) system comprising one or more vectors comprising: a) a first regulatory element operable in a eukaryotic cell operably linked to at least one nucleotide sequence encoding a CRISPR-Cas system guide RNA that hybridizes with the target sequence, and b) a second regulatory element operable in a eukaryotic cell operably linked to a nucleotide sequence encoding a Staphylococcus aureus Cas9 protein, wherein components (a) and (b) are located on same or different vectors of the system, whereby the guide RNA targets the target sequence and the Cas9 protein cleaves the DNA molecule, whereby expression of the at least one gene product is altered; and, wherein the Cas9 protein and the guide RNA do not naturally occur together.
地址 Cambridge MA US